Figures
Abstract
Atrial fibrillation (AF) is the most common cardiac arrhythmia, but our knowledge of the arrhythmogenic substrate is incomplete. Alternans, the beat-to-beat alternation in the shape of cardiac electrical signals, typically occurs at fast heart rates and leads to arrhythmia. However, atrial alternans have been observed at slower pacing rates in AF patients than in controls, suggesting that increased vulnerability to arrhythmia in AF patients may be due to the proarrythmic influence of alternans at these slower rates. As such, alternans may present a useful therapeutic target for the treatment and prevention of AF, but the mechanism underlying alternans occurrence in AF patients at heart rates near rest is unknown. The goal of this study was to determine how cellular changes that occur in human AF affect the appearance of alternans at heart rates near rest. To achieve this, we developed a computational model of human atrial tissue incorporating electrophysiological remodeling associated with chronic AF (cAF) and performed parameter sensitivity analysis of ionic model parameters to determine which cellular changes led to alternans. Of the 20 parameters tested, only decreasing the ryanodine receptor (RyR) inactivation rate constant (kiCa) produced action potential duration (APD) alternans seen clinically at slower pacing rates. Using single-cell clamps of voltage, fluxes, and state variables, we determined that alternans onset was Ca2+-driven rather than voltage-driven and occurred as a result of decreased RyR inactivation which led to increased steepness of the sarcoplasmic reticulum (SR) Ca2+ release slope. Iterated map analysis revealed that because SR Ca2+ uptake efficiency was much higher in control atrial cells than in cAF cells, drastic reductions in kiCa were required to produce alternans at comparable pacing rates in control atrial cells. These findings suggest that RyR kinetics may play a critical role in altered Ca2+ homeostasis which drives proarrhythmic APD alternans in patients with AF.
Author Summary
Atrial fibrillation is an irregular heart rhythm affecting millions of people worldwide. Effective treatment of this cardiac disorder relies upon our detailed knowledge and understanding of the mechanisms that lead to arrhythmia. Recent clinical observations have suggested that alternans, a phenomenon where the shape of the electrical signal in the heart alternates from beat to beat, may play an important role in this process, but the underlying mechanisms remain unknown. In this study, we use computational models to conduct a detailed examination of the causes and contributors to alternans associated with human atrial fibrillation. We find that in atria remodeled by atrial fibrillation, alternans appears near resting heart rates because several aspects of calcium cycling are disrupted in the atrial cells. In particular, the release and uptake of calcium from the cellular storage compartment, the sarcoplasmic reticulum, becomes imbalanced, leading to alternation in calcium signals from beat to beat. These findings provide important insights into the mechanisms of proarrhythmic alternans in human atrial fibrillation which may be used to develop novel therapeutic targets and treatment strategies in the future.
Citation: Chang KC, Bayer JD, Trayanova NA (2014) Disrupted Calcium Release as a Mechanism for Atrial Alternans Associated with Human Atrial Fibrillation. PLoS Comput Biol 10(12): e1004011. https://doi.org/10.1371/journal.pcbi.1004011
Editor: Andrew D. McCulloch, University of California San Diego, United States of America
Received: May 27, 2014; Accepted: October 29, 2014; Published: December 11, 2014
Copyright: © 2014 Chang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The authors confirm that all data underlying the findings are fully available without restriction. Parameter files, model files, and example scripts used to run the simulations presented in the paper can be found on FigShare. http://dx.doi.org/10.6084/m9.figshare.1201512.
Funding: This research was supported by National Institutes of Health grant DP1-HL123271 (http://www.nih.gov), the David C. Gakenheimer Fellowship, an ARCS/MWC Scholar Award from the KPMG Foundation (http://www.arcsfoundation.org), and a scholarship from the Whitaker International Program (http://www.whitaker.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: I have read the journal's policy and the authors of this manuscript have the following competing interests: Natalia A. Trayanova is a cofounder of CardioSolv, LLC. CardioSolv was not involved in this research.
Introduction
Atrial fibrillation (AF) is currently the most common cardiac rhythm disorder, posing a significant medical and economic challenge for the US health care system [1], [2]. This burden is likely to increase as the population ages and AF prevalence rises [3]. Effective prevention and treatment of AF depends upon advances in our understanding of underlying disease mechanisms. Although several features of AF electrophysiological remodeling have been identified over the past decades [4], [5], our knowledge about the arrhythmogenic substrate remains incomplete.
Beat-to-beat alternation in the shape of cardiac electrical signals, a phenomenon called alternans, has been observed in the atria of AF patients, but the mechanism underlying these alternans is not known [6]–[11]. Narayan et al. reported differences in the rate dependence of action potential duration (APD) alternans in patients, with APD alternans occurring at pacing rates near rest in AF patients but only at fast pacing rates in controls [8]. Narayan et al. also found that APD alternans always preceded AF initiation, indicating that alternans may play an important role in establishing the arrhythmogenic substrate and creating vulnerability to AF. Thus, a better understanding of AF arrhythmogenesis will likely depend upon identification of the mechanism driving atrial alternans at heart rates near rest.
Interestingly, in AF patients the slope of the APD restitution curve was <1 during APD alternans onset at slow pacing rates. This suggests that a cellular mechanism other than voltage-driven instability underlies APD alternans at heart rates near rest [9]. Altered Ca2+ handling in atrial myocytes is known to play a crucial role in the generation of AF triggers and in AF maintenance [12], [13]. Ca2+ cycling instabilities have been shown to underlie ventricular alternans in heart failure [14], [15], as well as atrial alternans in several non-AF animal models [16]–[18]. However, it is unknown whether these represent a plausible mechanism for atrial alternans in AF patients, particularly at heart rates near rest. We therefore sought to determine, using a computer model of human atrial tissue, whether Ca2+ handling abnormalities, or other electrophysiological changes that occur in AF, lead to APD alternans. We identified a critical change in the kinetics of the ryanodine receptor (RyR) that was responsible for APD alternans onset at slower pacing rates, and subsequently aimed to elucidate the mechanistic relationship between this disruption in RyR kinetics and alternans onset. To this end, we employed single-cell clamping of ionic model parameters and iterated map analysis in order to dissect the mechanisms which drive alternans in atrial tissue, as well as to provide important insights into the pathophysiological changes that contribute to the development of alternans in AF patients.
Results
APD alternans in the human AF tissue model
In order to investigate ionic mechanisms in human AF that contribute to the generation of atrial APD alternans at the tissue level, we created a computer model of human atrial tissue incorporating ionic remodeling associated with chronic AF (cAF), as described in Methods. The sensitivity of APD alternans to ionic model parameters was evaluated by varying parameters one at a time and applying the clinical pacing protocol used by Narayan et al. to induce APD alternans in AF patients [8] (see Table 1 and Methods). For control, a model of normal human atrial tissue was also simulated. We then assessed the magnitude and onset pacing cycle length (CL) of APD alternans by analyzing voltage traces from the recording electrode (Fig. 1A), as outlined in Methods.
(A) Atrial tissue mesh with stimulus and recording electrodes. (B) APD restitution curves for control tissue (black), cAF-remodeled tissue [19] (red), and cAFalt tissue with APD alternans onset and amplitude matching clinical data [8] (dotted red line). The RyR inactivation rate constant (kiCa) was reduced 50% in the cAF model to create the cAFalt model. APs (C) and CaTs (D) recorded from the last two beats at 400-ms pacing CL. Alternans are present in the cAFalt tissue but not in control or cAF tissue.
In the control model, significant APD alternans did not occur before loss of capture at 260 ms CL (Fig. 1B). However, in the cAF-remodeled tissue preparation, significant APD alternans appeared at a CL of 240 ms (Fig. 1B). Varying the RyR inactivation rate constant (kiCa) had the greatest effect on alternans onset CL in the human cAF-remodeled tissue (Fig. 2A). In fact, only reduction of kiCa resulted in alternans onset at CLs of 300–500 ms (Fig. 2B), matching alternans onset CLs observed in AF patients [8]. When other ionic model parameters were varied from their original cAF values, APD alternans either did not appear in the tissue model at CL≥300 ms (Fig. 2A, blue areas), appeared only at CL≤350 ms (Fig. 2A, red areas), or did not appear before loss of capture or conduction block occurred in the tissue (Fig. 2A, white spaces). These results suggest that altered RyR kinetics is the critical cellular component underlying the occurrence of APD alternans in AF patients at pacing rates near rest, and that kiCa plays a key role in this process.
Parameter sensitivity analysis was performed in cAF tissue in order to identify ionic model parameters that influence alternans. For panels A and B, APD alternans normalized magnitude (ANM) is indicated by the colorbar (>0.05 considered significant). (A) Parameters were scaled one at a time between 25% (short ticks) and 200% (long ticks) of their AF model values (25% increments). Only decreasing the RyR inactivation rate constant (kiCa) produced alternans at the longest CLs. (B) kiCa was scaled between 25% and 100% in 5% increments, producing a range of APD alternans onset CLs between 300–750 ms.
We also tested whether differences between left and right atrial electrophysiology affect alternans susceptibility using a right atrium (RA) version of the cAF model [19] in tissue simulations. Results for RA tissue were very similar to those for the left atrium (LA), demonstrating that modulation of kiCa could reproduce alternans observed at pacing rates near rest in both the LA and RA of AF patients [8] (S2 Figure).
When kiCa was decreased by 50% in the cAF model (we refer to this as the cAFalt ionic model), APD alternans onset data from the human AF tissue model agreed well with data from persistent AF patients. Significant APD alternans began at 400-ms CL (Fig. 1B, dotted red line), mean APD at onset was 229 ms, and APD alternans magnitude at onset was 27 ms (Fig. 1C, dotted red line). These metrics were each within one standard deviation (SD) of clinical observations [8] (Fig. 3). The cAFalt model also displayed noticeable alternans in intracellular Ca2+ ([Ca2+]i) at the onset CL (Fig. 1D). For both the cAF and cAFalt models, mean APDs were shorter than in the control model (Fig. 1B–C), and diastolic and systolic [Ca2+]i were lower than in control (Fig. 1D). At 400-ms CL in the cAFalt model, on the odd (long) vs. the even (short) beat (Fig. 4, blue vs. red), there was higher sarcoplasmic reticulum (SR) Ca2+ load before release (0.288 vs. 0.273 mM), higher peak RyR open probability (RyRo) (9.0e-4 vs. 4.7e-4), a larger intracellular Ca2+ transient (CaT) amplitude (Δ[Ca2+]i = 0.13 vs. 0.067 µM), similar L-type Ca2+ (LCC) current (integrated over one beat: 144 vs. 140 mC/F), and increased Na+/Ca2+ exchanger (NCX) current (INCX, integrated over one beat: 98.4 vs. 74.5 mC/F). The positive coupling between transmembrane potential (Vm) and Ca2+, with INCX as the primary electrogenic current, is consistent with experimental findings [20]. Since the magnitude and onset of APD alternans in the cAFalt model provided the best agreement with clinical APD alternans data (Fig. 3), we chose to use this model for subsequent investigations into the underlying causes of alternans occurrence.
Mean±SD alternans onset data during pacing in persistent AF patients (white bars) was taken from Table 2 in Ref. [8]. When the cAFalt tissue model was paced similarly, alternans onset CL, mean APD at onset, and APD alternans magnitude at onset were within one SD of clinical data (gray bars).
The odd (blue) and even (red) beats at the alternans onset CL (400 ms) are shown superimposed. Large Ca2+ release occurred during the long beat (blue traces). Top (left to right): transmembrane potential (Vm), intracellular Ca2+ ([Ca2+]i), and SR Ca2+concentration ([Ca2+]SR). Bottom (left to right): RyR open probability (RyRo), L-type Ca2+ current (ICa), Na+/Ca2+ exchanger current (INCX).
SR Ca2+ release underlies alternans onset
Since APD alternans throughout the homogenous cAFalt tissue preparation were concordant and of similar magnitude (S3 Figure), electrotonic effects and CV restitution were excluded as factors influencing these alternans. Indeed, APD and CaT alternans in the cAFalt tissue model were very similar to alternans in the isolated single-cell cAFalt model (Fig. 5, left column vs. Fig. 4, top row). We therefore concluded that cellular mechanisms gave rise to alternans in the cAFalt tissue model and decided to utilize single-cell simulations in order to investigate these mechanisms. We first used the ionic model variable clamping protocol described in detail in Methods. The percent change in APD and CaT alternans magnitudes, when each ionic model variable was clamped to its trace from either the even (short) or odd (long) steady-state beat at the alternans onset CL (400 ms), are summarized in Fig. 6 (right column: state variables, left column: currents and fluxes). Variables which resulted in >99% reduction in APD and CaT alternans magnitudes for both even and odd beat clamps were considered essential for alternans.
Traces of transmembrane potential (Vm, row 1), intracellular Ca2+ ([Ca2+]i, row 2), and SR Ca2+ ([Ca2+]SR, row 3) from two consecutive beats are superimposed to show alternans between even (red) and odd (blue) beats. Column 1: the unclamped cAFalt cell paced to steady state at 400-ms CL displayed alternans in Vm and Ca2+. The red traces depicted in column 1 were used to clamp Vm (column 2), [Ca2+]i (column 3), or [Ca2+]SR (column 4). Alternans persisted when Vm or [Ca2+]i is clamped, but clamping [Ca2+]SR eliminated alternans.
Results for all ionic model variable clamping simulations are summarized in bar graphs showing the percent changes in APD and CaT alternans magnitudes when model variables were clamped to even or odd beat waveforms. Alternans were eliminated (>99% decrease in APD and CaT alternans magnitudes for both even and odd beat waveforms) only when SR release variables were clamped (SR Ca2+ release flux, JSRCarel; RyR open probability, RyRo; RyR inactivated probability, RyRi; SR Ca2+ ([Ca2+]SR); and junctional Ca2+([Ca2+]j). Gating variable f (asterisk) displayed higher order instability when clamping to the even beat waveform, so the increase in alternans magnitude was considered infinitely large. Left column: SR fluxes and sarcolemmal currents. Right column: state variables.
Clamping Vm resulted in −61.8% change in CaT alternans magnitude for even beat clamps and +6.6% for odd beat clamps, demonstrating that the alternans were not voltage-driven (see even and odd beat clamps depicted in column 2 of Fig. 5 and S4 Figure, respectively). Clamping [Ca2+]i enhanced APD alternans (+55.2% and +75.8% for even and odd beat clamps, respectively, column 3 of Fig. 5 and S4 Figure). However, when SR Ca2+ ([Ca2+]SR) was clamped to either the even or odd beat waveforms, alternans in both APD and CaT were eliminated (<−99%), demonstrating that the alternans were driven by SR Ca2+ instability (column 4 of Fig. 5 and S4 Figure). In addition, four other variables could be clamped to the even or odd beat waveforms to eliminate APD and CaT alternans: RyR inactivated probability (RyRi), RyR open probability (RyRo), junctional Ca2+ ([Ca2+]j), and SR Ca2+ release flux (JSRCarel) (Fig. 6, and S5 and S6 Figures). All five of these variables were therefore critical for enabling alternans to occur at the onset CL. Furthermore, these variables directly impact SR Ca2+ release, implicating SR Ca2+ release as the underlying source of alternans in the cAFalt model.
There were two ionic model components which greatly reduced but did not eliminate alternans when clamped: sub-sarcolemmal Ca2+ ([Ca2+]sl) and sub-sarcolemmal Na+/Ca2+ exchanger current (INCXsl). Clamping [Ca2+]sl to the even beat eliminated all alternans; clamping to the odd beat greatly reduced APD and CaT alternans (−95.8% and −96.2%, respectively), although large alternation in SR load persisted (Fig. 6 and columns 1–2 of S7 Figure). Similarly, clamping INCXsl to the even beat waveform resulted in elimination of APD but not CaT alternans (+72.9%), while clamping to the odd beat waveform resulted in elimination of all alternans (Fig. 6 and columns 3–4 of S7 Figure). Hence, the SR Ca2+-driven instabilities produced alternans in Ca2+ cycling which were positively coupled to voltage through INCXsl and [Ca2+]sl.
Steepening of the SR Ca2+ release slope results in alternans
Increased steepness of the SR release-load relationship is a well-known mechanism for CaT alternans [21], [22]. The importance of SR Ca2+ release variables for APD and CaT alternans, as demonstrated by the results in Fig. 5, 6, and S4, S5, S6 Figures, led us to hypothesize that such a mechanism might give rise to Ca2+-driven alternans in the cAFalt model at pacing rates near rest. To test this, we compared the cAF and cAFalt ionic models under action potential (AP) voltage clamp conditions so that changes in CaT alternans would be due solely to changes in Ca2+ homeostasis rather than bidirectional coupling between Vm and Ca2+. After clamping each ionic model at a CL of 400 ms until steady state was reached, we perturbed [Ca2+]SR and tracked SR load and SR Ca2+ release on the subsequent clamped beats (see Methods for details). The SR release-load relationships for the cAF (black) and cAFalt (red) ionic models are depicted in Fig. 7 (left column, row 1). The slope of the release-load relationship in the cAFalt model ( = 3.1) was much greater than the slope in the cAF model (
= 1.7), confirming our hypothesis that differences between the cAF and cAFalt ionic models led to a steepening of the SR Ca2+ release slope.
Left column: simulations using the original cAF (black) and cAFalt (red) models. Right column: simulations in which the original RyR model, which included Ca2+-dependent inactivation, was replaced with the Sato-Bers RyR model, which utilizes calsequestrin regulation instead (see Table 2). In the Sato-Bers model, the SR is divided into junctional (JSR) and network (NSR) compartments. Top row: Total Ca2+ released from the SR is plotted against SR Ca2+ load under AP voltage clamp conditions (CL = 400 ms). The line of best fit is also plotted, with its slope value (the SR Ca2+ release slope) shown next to the data points. (In column 2, the first beat was excluded.) Modulating RyR inactivation by reducing kiCa (left column) or k34 (right column) by 50% increased the SR Ca2+ release slope in both models. Rows 2–6: Traces from a similar set of AP voltage clamp simulations. After reaching steady state (solid lines), SR or NSR load was perturbed at the beginning of the beat by a large amount (+20 µM, dashed lines) to illustrate the changes affecting SR Ca2+ release slope. Row 2: SR (JSR) Ca2+ ([Ca2+]SR/JSR). Row 3: RyR open probability (RyRo). Row 4: junctional Ca2+ ([Ca2+]j). Row 5: total Ca2+ released. Row 6: the difference in total Ca2+ release between perturbed and unperturbed (steady state) simulations. Insets in column 2, rows 3–4 show traces from t = 0–50 ms.
To better explain the differences between the cAF and cAFalt ionic models that gave rise to different SR Ca2+ release slopes, we first compared [Ca2+]SR, RyRo, [Ca2+]j, and cumulative Ca2+ release for the two models at steady state (Fig. 7, left column, rows 2–5, solid lines). In the cAFalt model, [Ca2+]SR at steady state was 19.7% lower than in the cAF model as a result of increased RyR opening (Fig. 7, left column, rows 2 and 3, red vs. black solid lines). Although this led to a 15.2% decrease in peak [Ca2+]j in the cAFalt model, the duration of the release event was prolonged (Fig. 7, left column, row 4, red vs. black solid lines). Consequently, though cumulative Ca2+ release in the cAFalt model initially lagged behind, at t≈90 ms it actually surpassed the cumulative release in the cAF model, ultimately resulting in a 3.4% increase in total release by the end of the beat (Fig. 7, left column, row 5, red vs. black solid lines).
To illustrate how these differences between the cAF and cAFalt ionic models impacted SR release slope, we applied a large perturbation to [Ca2+]SR (+20 µM) at the beginning of a clamped beat and compared the unperturbed (steady state, solid line) and perturbed (dotted line) traces for each model (Fig. 7, left column, rows 2–6). Higher SR load at the beginning of the beat led to increased SR release flux due to luminal Ca2+ regulation of the RyR (causing more opening), as well as to the increased concentration gradient between the SR and junctional compartments. In both the cAF and cAFalt models, these changes led to increased peak [Ca2+]j (+54.4% and +100%, respectively) and RyR opening (+64.6% and +129%, respectively) as a result of more Ca2+-induced Ca2+ release (Fig. 7, left column, rows 2–4). The positive feedback relationship between [Ca2+]j and RyR opening was strong enough such that when SR load was increased (Fig. 7, left column, row 2, dotted vs. solid lines), this actually resulted in a lower minimum [Ca2+]SR during release (−3.6% and −13.3% for cAF and cAFalt models, respectively). However, the amount of positive feedback differed between the cAF and cAFalt ionic models. Positive feedback amplifies changes in release inputs, such as SR load; therefore, in the cAF model, where [Ca2+]j is higher and positive feedback is stronger, the increase in [Ca2+]SR produced a slightly greater change in release (compared to the unperturbed, steady state simulation) during the rising phase of [Ca2+]j (t<48 ms) than in the cAFalt model (Fig. 7, left column, row 6, black vs. red).
By contrast, termination of release occurs through a negative feedback process, with RyRs inactivating upon the binding of junctional Ca2+. Negative feedback attenuates changes in release so that robust, fast termination of release is achieved even when a disturbance (such as a transient increase in SR load) occurs. In the cAFalt model, negative feedback is decreased both directly, via reduction of kiCa, and indirectly, via reduction in [Ca2+]j that occurs as a result of decreased SR load. This causes prolongation of the Ca2+ release event and a larger peak [Ca2+]j (Fig. 7, left column, row 4, red vs. black dotted lines). Consequently, when SR load was increased by the same amount in the cAF and cAFalt models, although the cAFalt model had a lesser initial change in release because of weaker positive feedback, it also had a greater final change in release, i.e. a steeper SR release-load relationship, because of weaker negative feedback (Fig. 7, left column, row 6, red vs. black).
The results in column 1 of Fig. 7 demonstrate how the steeper SR release slope in the cAFalt ionic model (as compared to the cAF ionic model) depends upon RyR inactivation by junctional Ca2+. However, recent work suggests that termination of release does not rely on direct Ca2+-dependent inactivation of the RyR but rather on local SR Ca2+ depletion [23]–[26]. In order to test whether steepening of the SR release slope could occur in the cAF model by an alternative release termination mechanism, we implemented a version of the cAF model in which the RyR Markov model was replaced with that of Sato and Bers and the SR was divided into junctional (JSR) and network (NSR) compartments [27] (see Table 2 and S1 Text). Termination of release in this alternative RyR model relies on calsequestrin (CSQN) binding to the RyR, which occurs as luminal [Ca2+] decreases causing changes in RyR opening and closing rates.
The effects of decreased RyR termination in the Sato-Bers RyR model are shown in the right column of Fig. 7. When the CSQN-bound RyR closing rate k34 (analagous to the inactivation rate kiCa in the original model) is decreased from 100% to 50% (cAFalt), steady-state Ca2+ concentrations change modestly as compared to the original RyR formulation (Fig. 7, black vs. red solid lines), but nevertheless display similar trends: [Ca2+]JSR decreases by 1.5% (vs. 19.7%, row 2), peak [Ca2+]j is reduced by 10.5% (vs. 15.2%, row 4) and delayed, and total release increases by 3.6% (vs. 3.4%, row 5). When [Ca2+]NSR is perturbed in the Sato-Bers models by +20 µM, Ca2+ release increases more in the cAFalt model than in the cAF model (Fig. 7, right column, row 6, red vs. black dotted lines). Consequently, the SR Ca2+ release slope is steeper in the cAFalt model ( = 3.7 vs 1.9, Fig. 7, right column, row 1). Thus, although changes in SR Ca2+ release slope in the original cAF model are caused by altered junctional Ca2+-dependent inactivation, altered SR Ca2+-dependent mechanisms of release termination can produce such changes in SR Ca2+ release slope as well.
Iterated map analysis
Although SR Ca2+ release slope is an important component of Ca2+ homeostasis, other aspects of Ca2+ cycling, such as SR Ca2+ uptake, could also have a significant impact. In order to understand how both SR release and uptake contribute to CaT alternans onset at slow pacing rates in human cAF cells, we used an iterated map analysis for investigating Ca2+ cycling stability under AP voltage clamp conditions. Three factors affecting Ca2+ cycling stability were included in the analysis: SR release, SR uptake, and cellular Ca2+ flux across the sarcolemma. The latter factor was included because Ca2+ content in the human atrial cell model varied significantly enough to affect alternans threshold predictions.
For each version of the human atrial cell model (cAF and control), we calculated the SR Ca2+ release slope (), the SR Ca2+ uptake factor (
), and the cellular Ca2+ efflux factor (
) [28], [29] for a range of kiCa values and pacing rates and compared the value of
to the threshold for alternans. For a typical range of parameter values (
, see S1 Text), the threshold value of
required for alternans is given by the following equation:
(1)Theoretical analysis predicts that the system is stable when
. Eq. 1 is graphed for a range of
values in Figs. 8A–C (dotted lines). Each curve represents the boundary between stable (no alternans) and unstable (alternans) Ca2+ cycling in the
-
plane for a particular value of
. As
increases (Fig. 8A–C, dark blue to dark red), the threshold curve steepens, indicating that increased Ca2+ extrusion from the cell has a protective effect, helping to restore Ca2+ content back to steady state following a perturbation. Thus, a higher value of
is required to reach alternans threshold for higher values of
. Note that in this theoretical approach, increased Ca2+ efflux (κ) has the opposite effect as in Qu et al. [29], suppressing rather than promoting Ca2+ alternans.
For each panel, SR Ca2+ release slope () is plotted against SR Ca2+ uptake factor (
), with cellular Ca2+ efflux factor (
) values indicated in the color bar. The boundaries between stable (no alternans) and unstable (alternans) regions in the
-
plane are denoted by dashed lines for different values of
(see Eq. 1). Circles and X's indicate the absence and presence of alternans, respectively. (A) Results for the cAF model. CL is varied, from 700 ms to 200 ms for the 100% kiCa model and from 700 ms to 300 ms for the 50% kiCa model (i.e., the cAFalt model), in 10-ms increments. At a CL of 390 ms, kiCa is scaled from 100% to 50% in 2% increments. (B) Same as in panel A, except that the control cell model is used, and kiCa is scaled from 100% to 16%. (C) Starting with the control cell parameter values, L-type Ca2+ current conductance (gCaL), maximal Na+/Ca2+ exchanger current (IbarNCX), and RyR activation rate constant (koCa) are sequentially scaled to cAF values, resulting in net decreases in
and
. Finally, kiCa is scaled to 50% (as in the cAFalt model), and
increases sufficiently to reach the alternans boundary (red X). If only gCaL is decreased to the cAF value, then alternans threshold is achieved at a higher kiCa value (72%, green X).
The effects of changing CL and changing kiCa are explored for the cAF model in Fig. 8A. At the default kiCa value (100%), as CL is decreased from 700 ms to 200 ms (−10 ms increments), decreases,
increases, and the system approaches the alternans threshold given by Eq. 1. The change in
values is non-monotonic, initially decreasing (orange to green) and then increasing (green to orange) as CL is decreased. However, the change in
has a minimal effect at small
values, since the threshold curves for different
values converge at
. At CL<220 ms, the cell begins to display alternans in Ca2+ cycling, coinciding with the iterated map parameter values residing very close to the theoretically predicted boundary given by Eq. 1 (Fig. 8A, orange X's). When kiCa is set at 50% of the default cAF value (cAFalt model), a similar trend is observed. However, the 50% kiCa cAF model reaches threshold at a lower pacing rate (CL = 390 ms for the 50% kiCa cAF model vs. 210 ms for the 100% kiCa cAF model, Fig. 8A, X's). This is primarily due to
increasing as kiCa is decreased, illustrated by the trajectory of the system in the
-
plane as CL is held constant at 390 ms but kiCa is decreased from 100% to 50% (Fig. 8A).
We next performed the same iterated map analysis for the control atrial cell model with varying CL and kiCa values (Fig. 8B). When kiCa is at 100%, decreases as CL is decreased. However, unlike in the cAF model, in the control case the value of
undergoes a net decrease as CL shortens from 700 to 200 ms. Ultimately, since both
and
decrease as CL is shortened, the control atrial cell (with kiCa at 100%) fails to reach threshold and remains in the stable, no alternans region. This suggests that alternans in control patients, which occur at CL<250 ms [8], are driven by voltage rather than Ca2+. As in the cAF model, the alternans threshold CL in the control model can be adjusted by modulating the value of kiCa (Fig. 8B, CL = 390 ms). However, in the control model, kiCa must be decreased much more than in the cAF model in order to reach
at a CL of 390 ms (kiCa reduced to 16% vs. 50%). The need for dramatic and possibly unrealistic reductions in kiCa to produce alternans at slow rates in control is consistent with the absence of alternans observed in control patients at CL≥250 ms [8].
To explain the difference in Ca2+ cycling properties of the cAF and control models, we examined the effects of cAF cellular remodeling on iterated map parameters. Stochastic ionic model parameter variation and regression analysis [30] (see S1 Text) predicted that of the ten model parameters altered in the control model to construct the cAF model, seven would have significant effects on alternans threshold CL (these are gCaL, gKur, koCa, IbarNCX, gto, gK1, and gNa, see S8 Figure). Of these seven parameters, three are involved in Ca2+ handling (gCaL, koCa, and IbarNCX). The effects of changing these three parameters from control to cAF values is depicted sequentially in Fig. 8C: starting with the default values for the control cell at a CL of 390 ms, first gCaL is decreased and then IbarNCX and koCa are increased to cAF values, resulting in an overall decrease in and
. Finally, when kiCa is decreased to the cAFalt value (50%), the large increase in
causes the system to reach
and alternate (Fig. 8C, red X). This illustrates why the control cell is less susceptible to CaT alternans than the cAF cell: at a given kiCa value and pacing rate, SR uptake efficiency (
) is higher in the control model, thus requiring a large increase in the pacing rate (which decreases
) and/or a large decrease in kiCa (which increases
) in order to reach
. Of the three cAF parameters which decrease
, however, gCaL is the most important for alternans onset, since remodeling of IbarNCX and koCa decreases
, while remodeling of gCaL increases
. When gCaL is remodeled and IbarNCX and koCa remain at control values, only a 28% decrease in kiCa is required to reach
(Fig. 8C, green X).
Discussion
Findings and significance
The first goal of this study was to identify the electrophysiological changes in human atrial cells that are responsible for the occurrence of APD alternans at heart rates near rest, as observed in AF patients. Using parameter sensitivity analysis, we found that of the 20 electrophysiological model variables tested, only changes in the RyR inactivation rate constant (kiCa) could produce APD alternans at relatively slow pacing rates in a tissue model of persistent/chronic AF. In particular, decreasing kiCa by 50% (the cAFalt model) produced a good match to clinical data. We next aimed to provide mechanistic insight into why disruption of RyR kinetics, together with other electrophysiological changes occurring in AF, leads to alternans onset at pacing rates near rest. We established that alternans in the cAFalt model at the onset CL were Ca2+-driven rather than voltage-driven, and that they depended upon SR Ca2+ release. Furthermore, CaT alternans occurred in the cAFalt model at relatively long CLs because of steep SR Ca2+ release slope and decreased SR Ca2+ uptake efficiency. Lastly, we demonstrated that the ability to generate alternans at slower pacing rates by modulating kiCa depended upon the negative feedback properties of SR Ca2+ release.
This study is the first to identify a possible mechanism for alternans occurring at slow heart rates in AF patients. Our novel findings show that alternans at slow rates is Ca2+-driven, brought about by AF-associated remodeling of the Ca2+ handling system in atrial cells. Clinical and experimental research has shown that atrial alternans is associated with disease progression in AF patients [8] and with increased AF susceptibility after myocardial infarction [31], [32] and atrial tachycardia [33], [34] in animal models. Additionally, CaT alternans have been studied in animal atrial myocytes [17], [18], [35] and in the intact atria of AF-prone mice [36]. However, the precise cellular mechanism underlying alternans at heart rates near rest in the remodeled human atria has not been previously identified, and a direct relationship between human AF and CaT alternans in the atria has not been established until now. Elucidating the mechanism driving alternans at slow rates is particularly important because APD oscillations appear to be closely linked to AF initiation [8]. If APD alternans play a direct role in AF initiation, the onset of alternans at slower pacing rates would indicate an increased susceptibility to arrhythmia in AF patients, consistent with clinical observations [8]. Identification of this mechanism would thus provide a significant scientific and clinical benefit, improving our understanding of arrhythmogenesis and aiding in the development of new targeted therapies for AF.
In this study, we demonstrate how different aspects of AF remodeling contribute to Ca2+-driven alternans onset at slower heart rates using a theoretical analysis of Ca2+ cycling. This analysis allowed us to quantitatively assess CaT alternans threshold under AP voltage clamp conditions in a detailed electrophysiological model, providing valuable insights into the effects of AF electrophysiological remodeling on Ca2+ handling and alternans. Furthermore, we identify a critical aspect of SR Ca2+ release—inactivation of the RyR—which is necessary for CaT alternans to occur at slow heart rates. These findings extend mechanistic insight about proarrhythmic ventricular Ca2+ remodeling [15], [37], [38] to the atria and may inform new therapeutic strategies to target the RyR and suppress Ca2+-driven alternans in the atria for the purposes of preventing or treating AF [36], [39].
RyR dysregulation in AF
The RyR has been the focus of several studies concerning trigger-mediated AF. In particular, disruption of RyR regulation has been shown to promote AF through increased RyR open probability, diastolic SR Ca2+ leak, and delayed afterdepolarizations [12], [39], [40]. Here we identify an additional pathological consequence of the disruption of RyR regulation in AF: Ca2+-driven alternans. Similar to what has been demonstrated with regards to Ca2+ sparks and triggered activity [39], we found that CaT alternans is coupled to voltage primarily through upregulated INCX, thus driving the generation of APD alternans. The RyR's central role in both alternans and triggers has important clinical implications, given the proarrhythmic consequences of interaction between ectopic activity and the arrhythmogenic substrate created by voltage alternans [41]. New drug treatments to restore the normal function of the RyR and NCX, and thereby prevent arrhythmogenic triggers and alternans, have the potential to provide more effective alternatives to current AF drug therapies which target voltage-gated ion channels and often have proarrhythmic side effects [39].
The signaling pathways involved in RyR dysfunction in AF have been the focus of much active research over the past several years [39], [40]. Possible molecular mechanisms which could account for reduced RyR inactivation include RyR hyperphosphorylation by CAMKII and PKA and dissociation of the RyR subunit FKBP12.6, which have been shown to increase RyR open probability and promote arrhythmia [42], although the exact role of these mechanisms in RyR dysregulation are still debated [43]. Calmodulin has also been shown to interact directly with the RyR to decrease its open probability [44]. Metabolic factors may play a role, since modulation of the RyR as a result of glycolytic inhibition has been linked to atrial alternans in non-AF animal models [16], [17], [35]. Such metabolic impairment is thought to contribute to profibrillatory remodeling in the atria [45]–[47]. The cAFalt model, with its reduction in kiCa, can be considered a phenomenological representation of the various signaling pathway disruptions leading to alternans, which were not represented in the original cAF model. As more information becomes available, incorporation of these signaling mechanisms into computational models may provide additional insights into how reduction in RyR inactivation leads to Ca2+-driven alternans at slow heart rates in AF patients.
The role of RyR refractoriness in CaT alternans
There is debate over whether CaT alternans depend primarily on SR Ca2+ load alternation or on RyR refractoriness [21], [41], [48]. Recent experiments [18], [49] and simulation studies [50]–[53] have shown that RyR refractoriness can drive CaT alternans under conditions where near-identical SR loads produce different amounts of SR release. In some simulation studies, this phenomenon was restricted to limited parameter values, clamping conditions, and cycle lengths [51], [52], while in a more recent modeling study focusing on atrial cells, SR load-independent alternans occurred over a broad range of pacing rates when the number of t-tubules was reduced [53]. Of note is the fact that many of these studies [51]–[53] utilized the same RyR gating scheme as this current study, yet they identified various mechanisms for CaT alternans. This demonstrates that the relative importance of the various mechanisms, whether SR load-driven, RyR refractoriness-driven, or otherwise, is highly context-dependent.
Although exploring the issue of SR load vs. RyR refractoriness was beyond the goals of the current study, our results suggest that in human cAF, both SR load alternation and RyR refractoriness are involved in alternans genesis at slower pacing rates. In our cAFalt model, alternation in all SR Ca2+ release variables, including [Ca2+]SR, RyR open probability, and RyR inactivated probability, was necessary for alternans at the onset CL of 400 ms (Fig. 6). In addition, SR uptake flux (Jserca) enhanced alternans when clamped (Fig. 6) and therefore suppressed alternans under normal pacing conditions, suggesting that SR load is indeed an important driver of CaT alternans in cAF and that upregulation of the SERCA pump may be an important therapeutic strategy for diminishing alternans. We also showed that CaT alternans occurred in the cAFalt model at slow pacing rates because decreased RyR inactivation resulted in steepening of the SR release-load relationship. Together, these results indicate that the interplay between SR load and RyR kinetics is responsible for alternans onset in human AF.
Other potential mechanisms for alternans susceptibility
The mechanisms for human atrial alternans susceptibility are likely to encompass a range of complex interactions at multiple scales of biology, which extend beyond the cellular-level mechanisms found here. In this study we examined the behavior of an atrial cell with well-developed t-tubules [19]. Research has shown that rat atrial cells have variable levels of t-tubule organization [54]. Such variation, if present in human atrial cells, would result in subcellular Ca2+ gradients which could make cells more susceptible to alternans [17], [55], [56]. Models of atrial myocytes incorporating detailed spatial descriptions [57] and local control of Ca2+ [58] will aid in future investigations of the subcellular mechanisms of cAF-related alternans.
In addition, the complex structure of the atria, including its normal conduction pathways [59] and fibrotic remodeling in AF [60], [61], may promote heterogeneity and discordant alternans, which significantly affect alternans dynamics and reentry initiation [9], [62]. Consideration of these factors in the future will further enrich the mechanistic insight gained from this current study and will advance our understanding of the role that alternans play in AF arrhythmogenesis.
Limitations
In many cell models, the effective refractory period (ERP) is not consistent with ERP at the tissue level [63]. Electrotonic effects in tissue and the whole heart can shorten or lengthen APD depending on which structures and cell types are coupled to each other. Furthermore, alternans in single cell models may not be predictive of alternans in tissue, where conduction alternans can occur. This was the case for the control atrial tissue model, in which loss of capture occurred at a CL of 260 ms before reaching the very fast pacing rates at which APD alternans were observed in human control patients (CL = 218±30 ms) [8]. However, alternans onset at clinically observed rates occurred in the single-cell control model (200 ms CL, S9 Figure, black curve) and when kiCa was reduced by 5% (230 ms CL, S9 Figure, red curve). This suggests that the ionic model may not be well-constrained for tissue simulations at very fast rates. However, this issue did not affect the study of alternans onset at slower pacing rates, as was observed in AF patients.
Our ionic model variable clamping protocol, which involved separately clamping the even or odd beat waveforms, was used to test for model variables which could robustly suppress alternans when clamped to either of two very different waveforms. An alternative approach would be to clamp model variables to the single unstable, non-alternating waveform obtained using a control algorithm [64]. This approach would allow more precise assessment of fixed point stability, since clamping is done at the point of instability rather than during the bistable (alternans) endpoint. However, for the purposes of quantifying the most important variables influencing instability, the clamping protocol used in this study was sufficient to identify the central role of SR Ca2+ release, which was later confirmed through iterated map analysis.
Recent experimental evidence points towards local SR Ca2+ depletion, rather than Ca2+-dependent RyR inactivation, as the main mechanism of SR release termination [23]–[26]. Although alternans in the cAFalt model relied on Ca2+-dependent RyR inactivation, other termination mechanisms which rely on SR Ca2+ (used in the Sato-Bers RyR model) may have similar effects on SR release slope and alternans susceptibility (Fig. 7, column 2). However, with the Sato-Bers RyR model, alternans and other complex oscillations began at the baseline pacing rate (750 ms CL, S10 Figure) and did not display the same rate dependence observed in patients [8]. In addition, large oscillations in CaT amplitude did not couple as strongly to voltage as with the original RyR, and oscillations were also attenuated in tissue (S10 Figure). Further work is needed to develop atrial cell models which incorporate current mechanistic understanding of SR Ca2+ release and which can also reproduce AF-related alternans rate dependence in tissue.
Conclusion
AF is associated with progressive changes in alternans onset in the human atria, with alternans occurring at slower heart rates as AF severity worsens. We found that the differences in alternans onset between AF and control patients could be accounted for by changes in the inactivation rate of the RyR in a model of human atrial cAF-remodeled tissue. Single-cell simulations revealed that alternans at these slow heart rates were driven by abnormal Ca2+ handling and the development of CaT alternans, and that changes in CaT alternans threshold resulted from steepening of the SR Ca2+ release slope, decreased SR Ca2+ uptake efficiency, and decreased inactivation of the RyR. These findings provide important insight into the mechanisms underlying proarrhythmic APD alternans occurring at slow heart rates in cAF patients. Such insight may aid in the development of targeted therapies and new treatment strategies for AF in the future.
Methods
Human AF tissue model
In order to investigate ionic mechanisms in human AF that contribute to the generation of atrial alternans at the tissue level, we created a computer model of human atrial tissue incorporating ionic remodeling associated with cAF. The atrial tissue preparation had dimensions of 0.33×0.33×9.9 mm3 (Fig. 1A), similar to the one used by Krummen et al. [65] Human atrial cell membrane kinetics were represented by a modified version of the Grandi-Pandit-Voigt (GPV) human atrial action potential model [19], which we refer to as the GPVm model. Detailed explanation and justification of the GPVm model modifications are provided in the supplement (S1, S2 Texts). Different types of human atrial tissue were modeled individually as homogenous tissue preparations, with each incorporating ionic changes appropriate for each tissue type. Both control and cAF-remodeled tissue, as well as left and right atrial tissue, were modeled using the parameter changes specified by Grandi et al. [19] (see S1 Text). The isotropic bulk conductivity value for the tissue was tuned to produce a conduction velocity of 0.62 m/s in control tissue [59], [66]. When cAF ionic remodeling was incorporated, the same bulk conductivity value produced a conduction velocity of 0.59 m/s. These values are within the reported ranges for control and AF conduction velocities [67].
Protocols for evaluating alternans in the human AF tissue model
We assessed alternans in the human AF tissue model by applying the clinical pacing protocol used by Narayan et al. to induce alternans in AF patients [8]. The tissue model was first initialized at all nodes with steady-state values from a single cell paced at 750-ms CL. The tissue was then paced from the stimulus electrode (Fig. 1A) for 20 beats at 750-ms CL and then for 74 beats at each subsequent CL, starting from 500 ms and shortened in 50-ms steps to 300 ms, and then shortened in 10-ms steps, until loss of capture or conduction block occurred.
Voltage traces from the recording electrode (Fig. 1A) were analyzed for APD alternans. APD was calculated as the time from maximal upstroke velocity to 90% repolarization of Vm from phase II amplitude. Alternans magnitude was quantified as the mean magnitude of change in APD over the last 10 pairs of beats (11 beats total). APD alternans normalized magnitude (ANM), obtained by dividing the alternans magnitude by the mean APD over the last 10 beats, was used to compare alternans between cells of varying APD. Alternans onset CL was defined as the longest CL for which ANM was greater than 5% [8].
Sensitivity of alternans to ionic model parameters
To identify cellular changes which could account for the onset of alternans in AF patients at CLs of 300–500 ms [8], we explored how ANM varied in human AF tissue models of both the left and right atrium as a result of changes in ionic model parameters. Of the 20 ionic model parameters tested, 10 were parameters altered in the GPVm model to represent cAF [19]; others were associated with L-type Ca2+ current (ICaL), rapidly activating potassium current (IKr), SR uptake, or SR release (Table 1). We scaled parameter values one at a time to 25–200% of the default left or right atrium values specified by Grandi et al. [19]; for each parameter value within this range, simulations were conducted to determine the presence of alternans (282 simulations total). In AF patients, average alternans onset CL was>300 ms [8], so pacing and alternans analysis was restricted to CLs≥300 ms.
Clamping protocols
After identifying conditions under which APD alternans magnitude and onset CL matched clinical observations, we utilized two different clamping approaches in order to investigate the key cellular properties that gave rise to these alternans, as described below. Further explanation of the rationale behind these methods can be found in Results.
Ionic model variable clamps.
To determine which human atrial ionic model variables drive the occurrence of alternans, we clamped individual ion currents and state variables in a single-cell model paced at a CL exhibiting alternans [15]. A model variable was clamped to its steady-state even or odd beat trace for the duration of 50 beats. This procedure was repeated for different model variables (membrane currents, SR fluxes, and all state variables excluding buffer concentrations), and APD alternans magnitude was quantified at the end of the 50 clamped beats. Additionally, the magnitude of alternans in Δ[Ca2+]i was quantified in the same manner as APD alternans magnitude, with Δ[Ca2+]i calculated as the difference between peak [Ca2+]i during the beat and minimum [Ca2+]i during the preceding diastolic interval (DI). Model variables were considered critical for alternans if clamping them to either the even or odd beat reduced both APD and CaT alternans magnitudes by >99% of baseline [15].
AP clamp.
To evaluate the Ca2+ cycling properties of the human atrial cell model under different pacing rates and parameter values, the following equation was used to clamp Vm to a generic atrial AP-like waveform so that comparisons between different conditions would not be influenced by variations in Vm:This approach has been used previously to investigate Ca2+ cycling properties in ventricular myocyte models [22], [50]. We set Vmax = 10 mV, Vrest = −75 mV, and APD = 200 ms. CL ranged from 200 to 700 ms.
The AP clamp enabled evaluation of Ca2+ cycling stability in the human atrial cell model via an iterated map analysis [22], [28], [68]. We used a similar approach as Qu et al. [29], where SR load and total Ca2+ content of the cell are tracked from beat to beat. In our analysis, Ca2+ cycling stability depended upon three iterated map parameters: SR Ca2+ release slope (), SR Ca2+ uptake factor (
), and cellular Ca2+ efflux factor (
). A detailed derivation of the iterated map stability criteria can be found in S1 Text.
To compute the iterated map parameters, a single atrial cell was repeatedly clamped to the AP waveform until model variables reached steady state. Following this, [Ca2+]SR was perturbed by ±1% at the beginning of an even beat, and total SR load, release, uptake, and cellular Ca2+ efflux per beat were recorded for the following 10 beats. For the Sato-Bers model, the first beat was excluded since it deviated noticeably from the linear response of later beats. This procedure was repeated starting with an odd beat so that data from a total of 40 beats were recorded (36 beats for the Sato-Bers model). Lastly, ,
, and
were computed as the slopes of the linear least-squares fit of the data (see S1 Text).
Supporting Information
S1 Figure.
Comparison of original and modified versions of the GPV ionic model in tissue. At 400-ms CL, the original GPV model did not propagate robustly in tissue (black line). When the fast sodium current kinetics was replaced with the kinetics from the Luo-Rudy dynamic model (LRd), normal propagation occurred (blue line). Applying the fast equilibrium approximation to select buffers (see S2 Text) had a negligible effect on simulation results (dotted green line).
https://doi.org/10.1371/journal.pcbi.1004011.s001
(TIF)
S2 Figure.
Sensitivity of APD alternans magnitude to ionic model parameters in RA cAF tissue during pacing. Parameter sensitivity analysis was performed in tissue with the right atrium version of the GPVm model incorporating cAF remodeling, in order to identify ionic model parameters that influence alternans. APD alternans normalized magnitude (ANM) is indicated by the colorbar (>0.05 considered significant). Parameters were scaled one at a time between 25% (short ticks) and 200% (long ticks) of their AF model values (25% increments). Results were similar to those obtained with the left atrium version of the model (see Fig. 2A), with alternans occurring at the longest CLs only when the RyR inactivation rate constant (kiCa) was decreased.
https://doi.org/10.1371/journal.pcbi.1004011.s002
(TIF)
S3 Figure.
APD alternans magnitudes in cAFalt tissue. The tissue preparation was paced from the stimulus electrode (see Fig. 1A), and APD alternans normalized magnitudes (ANMs) were quantified at each cycle length for every node along the tissue. When significant alternans was present in the tissue (ANM>0.05), all nodes had concordant alternans of similar magnitude.
https://doi.org/10.1371/journal.pcbi.1004011.s003
(TIF)
S4 Figure.
Voltage and Ca2+ odd beat clamps for the single-cell cAFalt model. Traces of transmembrane potential (Vm, row 1), intracellular Ca2+ ([Ca2+]i, row 2), and SR Ca2+ ([Ca2+]SR, row 3) from two consecutive beats are superimposed to show alternans between even (red) and odd (blue) beats. Column 1: the unclamped cAFalt cell paced to steady state at 400-ms CL displayed alternans in Vm and Ca2+. The blue traces depicted in column 1 were used to clamp Vm (column 2), [Ca2+]i (column 3), or [Ca2+]SR (column 4). Alternans persisted when Vm or [Ca2+]i was clamped, but clamping [Ca2+]SR eliminated alternans.
https://doi.org/10.1371/journal.pcbi.1004011.s004
(TIF)
S5 Figure.
SR Ca2+ release parameter even beat clamps for the single-cell cAFalt model. Traces of transmembrane potential (Vm, row 1), intracellular Ca2+ ([Ca2+]i, row 2), and SR Ca2+ ([Ca2+]SR, row 3) from two consecutive beats are superimposed to show alternans between even (red) and odd (blue) beats. Traces from the even beat at 400-ms CL pacing were used to clamp the relevant variable and are shown in row 4. Clamping RyR inactivated probability (RyRi, column 1), RyR open probability (RyRo, column 2), junctional Ca2+ ([Ca2+]j, column 3), or SR Ca2+ release flux (JSRCarel, column 4) eliminated alternans in Vm and Ca2+.
https://doi.org/10.1371/journal.pcbi.1004011.s005
(TIF)
S6 Figure.
SR Ca2+ release parameter odd beat clamps for the single-cell cAFalt model. Traces of transmembrane potential (Vm, row 1), intracellular Ca2+ ([Ca2+]i, row 2), and SR Ca2+ ([Ca2+]SR, row 3) from two consecutive beats are superimposed to show alternans between even (red) and odd (blue) beats. Traces from the odd beat at 400-ms CL pacing were used to clamp the relevant variable and are shown in row 4. Clamping RyR inactivated probability (RyRi, column 1), RyR open probability (RyRo, column 2), junctional Ca2+ ([Ca2+]j, column 3), or SR Ca2+ release flux (JSRCarel, column 4) eliminated alternans in Vm and Ca2+.
https://doi.org/10.1371/journal.pcbi.1004011.s006
(TIF)
S7 Figure.
Sub-sarcolemmal parameter clamps for the single-cell cAFalt model. Traces of transmembrane potential (Vm, row 1), intracellular Ca2+ ([Ca2+]i, row 2), and SR Ca2+ ([Ca2+]SR, row 3) from two consecutive beats are superimposed to show alternans between even (red) and odd (blue) beats. Traces from the even or odd beat at 400-ms CL pacing were used to clamp the relevant variable and are shown in row 4. Clamping sub-sarcolemmal Ca2+ ([Ca2+]sl) to the even beat (column 1) eliminated alternans in Vm and Ca2+, but clamping [Ca2+]sl to the odd beat (column 2) produced small alternans in Vm and [Ca2+]i and large alternans in [Ca2+]SR. Clamping sub-sarcolemmal Na+/Ca2+ exchanger current (INCXsl) to the even beat (column 3) eliminated alternans in APD but produced large alternans in [Ca2+]i and [Ca2+]SR. Clamping INCXsl to the odd beat (column 4) eliminated alternans in Vm and Ca2+.
https://doi.org/10.1371/journal.pcbi.1004011.s007
(TIF)
S8 Figure.
Multivariable regression between ionic model parameters and alternans threshold CL. (A) Bar graph of regression coefficient magnitudes. Twenty ionic model parameters were varied stochastically over 500 simulations to assess their effects on alternans cycle length (CL). Of the 500 simulations, 83 were excluded from the analysis because alternans threshold CL was below 100 ms or above 750 ms. Linear regression coefficients for each of the parameters are plotted in order of decreasing magnitude, with positive values plotted in red and negative values plotted in blue. Asterisks indicate p<0.05 for the t-statistic. (B) Bar graph of the predicted contribution of parameters to alternans threshold CL in the cAF-remodeled cell. Ten of the twenty parameters used in the regression analysis were altered from control values to represent cAF remodeling (increases and decreases indicated by upward and downward arrows, respectively). Parameters whose changes were predicted to increase (decrease) the alternans CL are plotted in red (blue). Some unaltered parameters had nonzero predicted contributions to alternans threshold CL due to nonzero sample means from the regression analysis. The alternans threshold CL predicted by regression analysis (245 ms) was very close to the actual alternans threshold CL determined by simulation (244 ms).
https://doi.org/10.1371/journal.pcbi.1004011.s008
(TIF)
S9 Figure.
Single-cell APD restitution in control model. With default model parameter values, APD alternans occurred at 200 ms CL (black). When the RyR inactivation rate constant (kiCa) was reduced to 95%, alternans occurred at slightly longer CLs (red). These results were comparable to alternans onset data from control patients [8].
https://doi.org/10.1371/journal.pcbi.1004011.s009
(TIF)
S10 Figure.
APD and CaT oscillations in single-cell and tissue models with Sato-Bers RyR formulation. Control (black), cAF (red), and cAFalt (dotted red line) versions of the model using the Sato-Bers RyR [27] were implemented in single cell (A and B) and in tissue (C and D). In the cAFalt model, the calsequestrin-bound RyR closing rate (k34) was decreased by 50%. APD (A and C) and CaT (B and D) restitution data are plotted showing the mean±SD range (control, gray shading, not visible; cAF, pink shading; cAFalt, red hatching). Oscillations in APD and CaT included but were not limited to alternans. Oscillations exhibited the reverse of the rate dependence observed in models using the original RyR formulation, with larger oscillations at longer CL. APD oscillations in these models were diminished as compared to the original models (see Fig. 1), and both APD and CaT oscillations were attenuated in tissue.
https://doi.org/10.1371/journal.pcbi.1004011.s010
(TIF)
Author Contributions
Conceived and designed the experiments: KCC JDB NAT. Performed the experiments: KCC. Analyzed the data: KCC. Contributed reagents/materials/analysis tools: KCC JDB. Wrote the paper: KCC NAT.
References
- 1. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG (1995) Prevalence, Age Distribution, and Gender of Patients With Atrial Fibrillation. Analysis and Implications. Arch Intern Med 155: 469–473.
- 2. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, et al. (2001) Prevalence of Diagnosed Atrial Fibrillation in Adults: National Implications for Rhythm Management and Stroke Prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study. JAMA 285: 2370–2375.
- 3. Coyne KS, Paramore C, Grandy S, Mercader M, Reynolds M, et al. (2006) Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value Health 9: 348–356.
- 4. Nattel S (2002) New ideas about atrial fibrillation 50 years on. Nature 415: 219–226.
- 5. Nattel S, Burstein B, Dobrev D (2008) Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ Arrhythmia Electrophysiol 1: 62–73.
- 6. Kim B-S, Kim Y-H, Hwang G-S, Pak H-N, Lee SC, et al. (2002) Action potential duration restitution kinetics in human atrial fibrillation. J Am Coll Cardiol 39: 1329–1336.
- 7. Narayan SM, Bode F, Karasik PL, Franz MR (2002) Alternans of Atrial Action Potentials During Atrial Flutter as a Precursor to Atrial Fibrillation. Circulation 106: 1968–1973.
- 8. Narayan SM, Franz MR, Clopton P, Pruvot EJ, Krummen DE (2011) Repolarization alternans reveals vulnerability to human atrial fibrillation. Circulation 123: 2922–2930.
- 9. Franz MR, Jamal SM, Narayan SM (2012) The role of action potential alternans in the initiation of atrial fibrillation in humans: a review and future directions. Europace 14: v58–64.
- 10. Hiromoto K, Shimizu H, Furukawa Y, Kanemori T, Mine T, et al. (2005) Discordant repolarization alternans-induced atrial fibrillation is suppressed by verapamil. Circ J 69: 1368–1373.
- 11. Lalani GG, Schricker AA, Clopton P, Krummen DE, Narayan SM (2013) Frequency analysis of atrial action potential alternans: a sensitive clinical index of individual propensity to atrial fibrillation. Circ Arrhythmia Electrophysiol 6: 859–867.
- 12. Nattel S, Dobrev D (2012) The multidimensional role of calcium in atrial fibrillation pathophysiology: mechanistic insights and therapeutic opportunities. Eur Heart J 33: 1870–1877.
- 13. Heijman J, Voigt N, Nattel S, Dobrev D (2012) Calcium handling and atrial fibrillation. Wiener medizinische Wochenschrift 162: 287–291.
- 14. Narayan SM, Bayer JD, Lalani G, Trayanova NA (2008) Action potential dynamics explain arrhythmic vulnerability in human heart failure: a clinical and modeling study implicating abnormal calcium handling. J Am Coll Cardiol 52: 1782–1792.
- 15. Bayer JD, Narayan SM, Lalani GG, Trayanova NA (2010) Rate-dependent action potential alternans in human heart failure implicates abnormal intracellular calcium handling. Heart Rhythm 7: 1093–1101.
- 16. Hüser J, Wang YG, Sheehan KA, Cifuentes F, Lipsius SL, et al. (2000) Functional coupling between glycolysis and excitation-contraction coupling underlies alternans in cat heart cells. J Physiol 524: 795–806.
- 17. Blatter LA, Kockskamper J, Sheehan KA, Zima AV, Huser J, et al. (2002) Local calcium gradients during excitation-contraction coupling and alternans in atrial myocytes. J Physiol 546: 19–31.
- 18. Shkryl VM, Maxwell JT, Domeier TL, Blatter LA (2012) Refractoriness of sarcoplasmic reticulum Ca2+ release determines Ca2+ alternans in atrial myocytes. Am J Physiol Heart Circ Physiol 302: H2310–20.
- 19. Grandi E, Pandit SV, Voigt N, Workman AJ, Dobrev D, et al. (2011) Human Atrial Action Potential and Ca2+ Model: Sinus Rhythm and Chronic Atrial Fibrillation. Circ Res 109: 1055–1066.
- 20. Wan X, Cutler M, Song Z, Karma A, Matsuda T, et al. (2012) New experimental evidence for mechanism of arrhythmogenic membrane potential alternans based on balance of electrogenic I(NCX)/I(Ca) currents. Heart Rhythm 9: 1698–1705.
- 21. Díaz ME, O'Neill SC, Eisner DA (2004) Sarcoplasmic reticulum calcium content fluctuation is the key to cardiac alternans. Circ Res 94: 650–656.
- 22. Xie L-H, Sato D, Garfinkel A, Qu Z, Weiss JN (2008) Intracellular Ca alternans: coordinated regulation by sarcoplasmic reticulum release, uptake, and leak. Biophys J 95: 3100–3110.
- 23. Sobie EA, Lederer WJ (2012) Dynamic local changes in sarcoplasmic reticulum calcium: physiological and pathophysiological roles. J Mol Cell Cardiol 52: 304–311.
- 24. Radwański PB, Belevych AE, Brunello L, Carnes CA, Györke S (2013) Store-dependent deactivation: cooling the chain-reaction of myocardial calcium signaling. J Mol Cell Cardiol 58: 77–83.
- 25. Laver DR, Kong CHT, Imtiaz MS, Cannell MB (2013) Termination of calcium-induced calcium release by induction decay: an emergent property of stochastic channel gating and molecular scale architecture. J Mol Cell Cardiol 54: 98–100.
- 26. Stern MD, Ríos E, Maltsev VA (2013) Life and death of a cardiac calcium spark. J Gen Physiol 142: 257–274.
- 27. Sato D, Bers DM (2011) How does stochastic ryanodine receptor-mediated Ca leak fail to initiate a Ca spark? Biophys J 101: 2370–2379.
- 28. Weiss JN, Karma A, Shiferaw Y, Chen P-S, Garfinkel A, et al. (2006) From pulsus to pulseless: the saga of cardiac alternans. Circ Res 98: 1244–1253.
- 29. Qu Z, Shiferaw Y, Weiss J (2007) Nonlinear dynamics of cardiac excitation-contraction coupling: An iterated map study. Phys Rev E 75: 011927.
- 30. Sobie EA (2009) Parameter sensitivity analysis in electrophysiological models using multivariable regression. Biophys J 96: 1264–1274.
- 31. Miyauchi Y, Zhou S, Okuyama Y, Miyauchi M, Hayashi H, et al. (2003) Altered atrial electrical restitution and heterogeneous sympathetic hyperinnervation in hearts with chronic left ventricular myocardial infarction: implications for atrial fibrillation. Circulation 108: 360–366.
- 32. Kettlewell S, Burton FL, Smith GL, Workman AJ (2013) Chronic myocardial infarction promotes atrial action potential alternans, afterdepolarizations, and fibrillation. Cardiovasc Res 99: 215–224.
- 33. Jousset F, Tenkorang J, Vesin J-M, Pascale P, Ruchat P, et al. (2012) Kinetics of atrial repolarization alternans in a free-behaving ovine model. J Cardiovasc Electrophysiol 23: 1003–1012.
- 34. Monigatti-Tenkorang J, Jousset F, Pascale P, Vesin J-M, Ruchat P, et al. (2014) Intermittent Atrial Tachycardia Promotes Repolarization Alternans and Conduction Slowing During Rapid Rates, and Increases Susceptibility to Atrial Fibrillation in a Free-Behaving Sheep Model. J Cardiovasc Electrophysiol 25: 418–427.
- 35. Kockskämper J, Zima AV, Blatter LA (2005) Modulation of sarcoplasmic reticulum Ca2+ release by glycolysis in cat atrial myocytes. J Physiol 564: 697–714.
- 36. Xie W, Santulli G, Guo X, Gao M, Chen B-X, et al. (2013) Imaging atrial arrhythmic intracellular calcium in intact heart. J Mol Cell Cardiol 64: 120–123.
- 37. Livshitz LM, Rudy Y (2007) Regulation of Ca2+ and electrical alternans in cardiac myocytes: role of CAMKII and repolarizing currents. Am J Physiol Heart Circ Physiol 292: H2854–66.
- 38. Belevych AE, Terentyev D, Viatchenko-Karpinski S, Terentyeva R, Sridhar A, et al. (2009) Redox modification of ryanodine receptors underlies calcium alternans in a canine model of sudden cardiac death. Cardiovasc Res 84: 387–395.
- 39. Dobrev D, Voigt N, Wehrens XHT (2011) The ryanodine receptor channel as a molecular motif in atrial fibrillation: pathophysiological and therapeutic implications. Cardiovasc Res 89: 734–743.
- 40. Lederer WJ, Bers DM, Eisner DA, Marx SO, Marks AR (2013) Dysfunctional ryanodine receptors in the heart: New insights into complex cardiovascular diseases. J Mol Cell Cardiol 58: 225–231.
- 41. Laurita KR, Rosenbaum DS (2008) Cellular mechanisms of arrhythmogenic cardiac alternans. Prog Biophys Mol Biol 97: 332–347.
- 42. Dobrev D, Wehrens XHT (2014) Role of RyR2 Phosphorylation in Heart Failure and Arrhythmias: Controversies Around Ryanodine Receptor Phosphorylation in Cardiac Disease. Circ Res 114: 1311–1319.
- 43. Houser SR (2014) Role of RyR2 Phosphorylation in Heart Failure and Arrhythmias: Protein Kinase A-Mediated Hyperphosphorylation of the Ryanodine Receptor at Serine 2808 Does Not Alter Cardiac Contractility or Cause Heart Failure and Arrhythmias. Circ Res 114: 1320–1327.
- 44. Arnáiz-Cot JJ, Damon BJ, Zhang X-H, Cleemann L, Yamaguchi N, et al. (2013) Cardiac calcium signaling pathologies associated with defective calmodulin regulation of type 2 ryanodine receptor. J Physiol 591: 4287–4299.
- 45. Mayr M, Yusuf S, Weir G, Chung Y-L, Mayr U, et al. (2008) Combined metabolomic and proteomic analysis of human atrial fibrillation. J Am Coll Cardiol 51: 585–594.
- 46. De Souza AI, Cardin S, Wait R, Chung Y-L, Vijayakumar M, et al. (2010) Proteomic and metabolomic analysis of atrial profibrillatory remodelling in congestive heart failure. J Mol Cell Cardiol 49: 851–863.
- 47. Kourliouros A, Yin X, Didangelos A, Hosseini MT, Valencia O, et al. (2011) Substrate modifications precede the development of atrial fibrillation after cardiac surgery: a proteomic study. Ann Thorac Surg 92: 104–110.
- 48. Picht E, DeSantiago J, Blatter LA, Bers DM (2006) Cardiac alternans do not rely on diastolic sarcoplasmic reticulum calcium content fluctuations. Circ Res 99: 740–748.
- 49. Wang L, Myles RC, De Jesus NM, Ohlendorf AKP, Bers DM, et al. (2014) Optical mapping of sarcoplasmic reticulum Ca2+ in the intact heart: ryanodine receptor refractoriness during alternans and fibrillation. Circ Res 114: 1410–1421.
- 50. Restrepo JG, Weiss JN, Karma A (2008) Calsequestrin-mediated mechanism for cellular calcium transient alternans. Biophys J 95: 3767–3789.
- 51. Rovetti R, Cui X, Garfinkel A, Weiss JN, Qu Z (2010) Spark-induced sparks as a mechanism of intracellular calcium alternans in cardiac myocytes. Circ Res 106: 1582–1591.
- 52. Alvarez-Lacalle E, Cantalapiedra IR, Peñaranda A, Cinca J, Hove-Madsen L, et al. (2013) Dependency of calcium alternans on ryanodine receptor refractoriness. PLoS One 8: e55042.
- 53. Lugo CA, Cantalapiedra IR, Peñaranda A, Hove-Madsen L, Echebarria B (2014) Are SR Ca content fluctuations or SR refractoriness the key to atrial cardiac alternans?: insights from a human atrial model. AJP Hear Circ Physiol 306: H1540–H1552.
- 54. Frisk M, Koivumäki JT, Norseng PA, Maleckar MM, Sejersted OM, et al. (2014) Variable t-tubule organization and Ca2+ homeostasis across the atria. Am J Physiol Heart Circ Physiol 307: H609–20.
- 55. Thul R, Coombes S, Roderick HL, Bootman MD (2012) Subcellular calcium dynamics in a whole-cell model of an atrial myocyte. Proc Natl Acad Sci U S A 109: 2150–2155.
- 56. Li Q, O'Neill SC, Tao T, Li Y, Eisner D, et al. (2012) Mechanisms by which Cytoplasmic Calcium Wave Propagation and Alternans Are Generated in Cardiac Atrial Myocytes Lacking T-Tubules–Insights from a Simulation Study. Biophys J 102: 1471–1482.
- 57. Koivumäki JT, Korhonen T, Tavi P (2011) Impact of sarcoplasmic reticulum calcium release on calcium dynamics and action potential morphology in human atrial myocytes: a computational study. PLoS Comput Biol 7: e1001067.
- 58. Voigt N, Heijman J, Wang Q, Chiang DY, Li N, et al. (2013) Cellular and Molecular Mechanisms of Atrial Arrhythmogenesis in Patients With Paroxysmal Atrial Fibrillation. Circulation 129: 145–156.
- 59. Harrild DM, Henriquez CS (2000) A Computer Model of Normal Conduction in the Human Atria. Circ Res 87: e25–36.
- 60. Krogh-Madsen T, Abbott GW, Christini DJ (2012) Effects of electrical and structural remodeling on atrial fibrillation maintenance: a simulation study. PLoS Comput Biol 8: e1002390.
- 61. McDowell KS, Vadakkumpadan F, Blake R, Blauer J, Plank G, et al. (2013) Mechanistic inquiry into the role of tissue remodeling in fibrotic lesions in human atrial fibrillation. Biophys J 104: 2764–2773.
- 62. Qu Z, Garfinkel A, Chen P-S, Weiss JN (2000) Mechanisms of Discordant Alternans and Induction of Reentry in Simulated Cardiac Tissue. Circulation 102: 1664–1670.
- 63. Defauw A, Kazbanov IV, Dierckx H, Dawyndt P, Panfilov AV (2013) Action potential duration heterogeneity of cardiac tissue can be evaluated from cell properties using Gaussian Green's function approach. PLoS One 8: e79607.
- 64. Jordan PN, Christini DJ (2007) Characterizing the contribution of voltage- and calcium-dependent coupling to action potential stability: implications for repolarization alternans. Am J Physiol Heart Circ Physiol 293: H2109–18.
- 65. Krummen DE, Narayan SM (2009) Mechanisms for the initiation of human atrial fibrillation. Heart Rhythm 6: S12–6.
- 66. Krummen DE, Bayer JD, Ho J, Ho G, Smetak MR, et al. (2012) Mechanisms for Human Atrial Fibrillation Initiation: Clinical and Computational Studies of Repolarization Restitution and Activation Latency. Circ Arrhythm Electrophysiol 5: 1149–1159.
- 67. Dössel O, Krueger MW, Weber FM, Wilhelms M, Seemann G (2012) Computational modeling of the human atrial anatomy and electrophysiology. Med Biol Eng Comput 50: 773–799.
- 68. Shiferaw Y, Watanabe MA, Garfinkel A, Weiss JN, Karma A (2003) Model of intracellular calcium cycling in ventricular myocytes. Biophys J 85: 3666–3686.
- 69. Vigmond EJ, Hughes M, Plank G, Leon LJ (2003) Computational tools for modeling electrical activity in cardiac tissue. J Electrocardiol 36: 69–74.
- 70. Plank G, Zhou L, Greenstein JL, Cortassa S, Winslow RL, et al. (2008) From mitochondrial ion channels to arrhythmias in the heart: computational techniques to bridge the spatio-temporal scales. Philos Trans R Soc Ser A Math Phys Eng Sci 366: 3381–3409.
- 71. Vigmond EJ, Weber dos Santos R, Prassl AJ, Deo M, Plank G (2008) Solvers for the cardiac bidomain equations. Prog Biophys Mol Biol 96: 3–18.